Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing / D'Amico, F., Fiorino, G., Peyrin-Biroulet, L., Danese, S.. - In: IMMUNOTHERAPY. - ISSN 1750-743X. - 11:7(2019), pp. 565-575. [10.2217/imt-2018-0209]
Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing
Danese S
2019-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Vedolizumab for the treatment of inflammatory bowel diseases from symptomatic control to mucosal healing.pdf
solo gestori archivio
Dimensione
730.18 kB
Formato
Adobe PDF
|
730.18 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


